European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

First Page		Document Content
Medicine Clinical medicine Cancer Tyrosine kinase receptors Breast cancer Atezolizumab ROS1 Triple-negative breast cancer Anaplastic lymphoma kinase Trastuzumab emtansine Entrectinib Metastatic breast cancer		European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals Add to Reading List Source URL: www.roche.com Download Document from Source Website File Size: 2,40 MB Share Document on Facebook

	Open Up More Treatment Possibilities For Your Patients About FoundationOne® FoundationOne is a validated comprehensive Genomic Profile that interrogates the entire coding sequence of 315 cancer-related genes plus selec DocID: 1m3P8 - View Document
	MONROE: Measuring Mobile Broadband Networks in Europe Özgü Alay1 , Andra Lutu1 , David Ros1 , Rafael Garcia2 , Vincenzo Mancuso2 Audun Fosselie Hansen3 , Anna Brunstrom4 , Marco Ajmone Marsan2,5 and Hakon Lonsethagen6 DocID: 1lzE8 - View Document
	Combined TIRF-AFM Setup: Controlled Quenching of Individual Quantum Dots Rainer Eckel1, Volker Walhorn1, Christoph Pelargus1, Jörg Martini1, Thomas Nann2, Dario Anselmetti1, and Robert Ros1† 1 DocID: 18zwp - View Document
	PBL/Alterra Note Climate effects of wood used for bioenergy Jan P.M. Ros1 DocID: 16gOm - View Document
	K-dimensional trees for continuous traffic classification Valent´ın Carela-Espa˜ nol1, Pere Barlet-Ros1, Marc Sol´e-Sim´o1, Alberto 2 Dainotti , Walter de Donato2 , and Antonio Pescap´e2 DocID: YLGA - View Document